Results 81 to 90 of about 162,034 (289)
Antisense oligonucleotides used in this study.
Antisense oligonucleotides used in this study.
Willem M. H. Hoogaars (430632) +8 more
core +1 more source
Gastric cancer metastasis should be considered according to its anatomical route, because lymphatic, peritoneal, and hematogenous dissemination involve partly distinct molecular mechanisms. This review summarizes metastasis pattern‐associated and pattern‐specific molecules identified using surgical specimens, evaluates their evidence and translational ...
Mitsuro Kanda
wiley +1 more source
Antisense oligonucleotides tested in the present study.
Antisense oligonucleotides tested in the present study.
Steve D. Wilton (190383) +6 more
core +1 more source
Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment
Objective The antisense oligonucleotide tofersen is the first disease‐modifying drug for SOD1‐related amyotrophic lateral sclerosis (ALS) and was approved because of its ability to reduce SOD1 protein and neurofilament levels. The effect of tofersen on SOD1 activity is unclear but of clinical relevance because homozygous SOD1 mutations, linked to ...
Katharina Goehring +18 more
wiley +1 more source
2′-OMe antisense oligonucleotides.
2′-OMe antisense oligonucleotides.
Agnieszka Gorska (482400) +5 more
core +1 more source
The mdx mouse model of muscular dystrophy has a premature stop codon preventing production of dystrophin. This results in a progressive phenotype causing centronucleation of skeletal muscle fibers, muscle weakness and fibrosis and kyphosis.
Laws, Nicola +6 more
core +1 more source
Antisense Oligonucleotides: Potential Therapeutics in Neurology and Beyond
A brief discussion of Antisense Oligonucleotides and their application to Neurology and COVID-19.
Knepp, Bodie
core +1 more source
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: A comparison of tricyclo-DNA with LNA [PDF]
The nuclear antisense properties of a series of tricyclo(tc)-DNA oligonucleotide 9-15mers, targeted against the 3' and 5' splice sites of exon 4 of cyclophilin A (CyPA) pre-mRNA, were evaluated in HeLa cells and compared with those of corresponding LNA ...
Schümperli, Daniel +10 more
core +3 more sources
Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
Antisense oligonucleotides, which are used to silence target genes, are gaining attention as a novel drug discovery modality for proteinopathies. However, while clinical trials for neurodegenerative diseases like amyotrophic lateral sclerosis have been ...
Daisuke Ito, Kensuke Okada
doaj +1 more source
Antisense Oligonucleotides Targeting SARS-CoV-2
COVID-19 is treated with antisense oligonucleotides (ASOs) targeting SARS-CoV-2 viral RNAs or human ACE2 RNA.
Karstensen, Kasper; id_orcid +3 more
core

